Hancock Whitney Corp shaved off 5.6% of its Amgen holdings during the fourth quarter, selling 2,474 shares but still ...

Clinical academia is on a steep decline globally. In the UK, a 6% reduction in the number of clinical academics since 2012 has been reported, with the number of senior lecturer level researchers ...

(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest ...

THOUSAND OAKS, Calif., April 25, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $900 million expansion of its ...

CytomX Therapeutics CTMX, a clinical-stage oncology company, is expected to beat first-quarter 2025 earnings when it reports ...

We are thrilled to welcome Chris to our team at this exciting time for Design, as we advance our portfolio of GeneTAC ® small molecules toward key clinical milestones,” said Pratik Shah, Ph.D., ...

"Amgen’s Phase III trial of Imdelltra meets primary endpoint for SCLC" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has ...

Amgen Research and Development executive vice-president Jay Bradner said: “SCLC is one of the most aggressive malignancies, with a high unmet need for more effective therapies. The topline results ...

Sandoz and Amgen face off in a legal battle over market access for Enbrel biosimilars. Credit: Richard Drury via Getty Images. Sandoz has filed an antitrust lawsuit in the US against Amgen, ...

While Sony used to offer free trials for new users to its online service, PlayStation Plus does not currently offer any free trials. There really isn't a direct replacement for PS Plus as it's ...

THOUSAND OAKS, Calif. - Amgen (NASDAQ:AMGN), a biotechnology leader with a market capitalization of $151.3 billion and impressive gross margins of nearly 69%, reported that its Phase 3 DeLLphi-304 ...